Table 1.
Characteristics of population and study type for included studies.
Bart [3] | Costanzo [7] | Giglioli [4] | Bart [10] | Hanna [6] | Chung [21] | Marenzi [17] | Costanzo [5] | Şeker [22] | Hu [16] | |
---|---|---|---|---|---|---|---|---|---|---|
Year | 2005 | 2007 | 2011 | 2012 | 2012 | 2014 | 2014 | 2016 | 2016 | 2020 |
Trial | RAPID-CHF | UNLOAD | ULTRADISCO | CARRESS-HF | - | - | CUORE | AVOID-HF | - | - |
Country | USA | USA | Italy | Canada, USA | USA | USA | Italy | USA | Turkey | China |
Sample size | 40 | 200 | 30 | 188 | 36 | 16 | 56 | 221 | 30 | 100 |
Intervention (UF) cohort size | 20 | 100 | 15 | 94 | 19 | 8 | 27 | 110 | 10 | 40 |
Diuretics cohort size |
20 | 100 | 15 | 94 | 17 | 8 | 29 | 111 | 20 | 60 |
Mean ± SD age of UF cohort | 67.5 * | 62 ± 15 | 72.4 ± 14.1 | 68.9 ± 12.0 | 60 ± 9.1 | 69 ± 14 | 75 ± 8 | 67 ± 13 | 66.5 ± 9.8 | 70.6 ± 10.44 |
Mean ± SD age of diuretics cohort | 69.5 * | 63 ± 14 | 65.8 ± 18.4 | 67.1 ± 13.7 | 59 ± 15.5 | 74 ± 12 | 73 ± 9 | 67 ± 13 | 66.8 ±10.2 | 73.52 ± 9.83 |
% Male in UF | 70 | 70 | 87 | 78 | 84.2 | 87.5 | 81 | 69.1 | 60 | 55 |
% Male in diuretics |
70 | 68 | 87 | 72 | 76.5 | 100 | 83 | 73 | 65 | 55 |
UF, ultrafiltration; % percentage; * represents median values.